drugset / Trial / NCT00239811

Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

NCT00239811

Phase 3 Completed 684 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the long term safety and efficacy of FTY720 combined with cyclosporine and corticosteroids in patients receiving a kidney organ transplant

Timeline

Start
2004-04
Primary completion
2006-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fingolimod Small molecule

Indications

No indication recorded.